Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (2)
  • 2024 (5)
  • 2023 (7)
  • 2022 (12)
  • 2021 (16)
  • 2020 (4)
  • 2019 (1)

Subject

  • Drug Trafficking (33)
  • Prescription Drugs (19)
  • Diversion Division (10)
  • Fake Pills (10)
  • Synthetic drugs (8)
  • Guns/Weapons (7)
  • OCDETF/Task Force (6)
  • Seizures (Drugs/Property) (6)
  • Task Forces/Task Force Officers (6)
  • Overdose (4)
  • Major Law Enforcement Operation (3)
  • Arrests/Convictions - Major (2)
  • Guilty Plea (2)
  • Asset Forfeiture (1)
  • Dark Web- Internet Trafficking (1)
  • Public and Media Affairs - also see Congressional Affairs (1)
  • Take Back Day (1)
  • Pharmaceuticals/Pharmacists/Physicians (12)

Drug Name

  • Opioids (14)
  • Fentanyl (8)
  • Hydromorphone (6)
  • Benzodiazepines (2)
  • Synthetic Opioids (2)
  • Amphetamines (1)
  • Methamphetamine (1)
  • Morphine (1)
  • Steroids (1)
  • Oxycodone (12)

Field Division

  • Washington, DC (4)
  • New York (2)
  • Atlanta (1)
  • Chicago (1)
  • Miami (1)
  • New England (1)
  • New Jersey (1)
  • St. Louis (1)
Clear All Results
PRESS RELEASE

Northeast Hospital Agrees to Pay $1.9 Million To Resolve Allegations of Controlled Substance Recordkeeping Violations

Diciembre 07, 2022
BOSTON – Northeast Hospital Corporation (Northeast), part of Beth Israel Lahey Health, has agreed to pay $1.9 million in civil penalties to resolve allegations that Northeast violated the Controlled Substance Act (the CSA) by failing to keep accurate records of controlled substances, including opioids. The CSA requires accurate inventorying and...
Diciembre 07, 2022
PRESS RELEASE

Dentist and TOBAY Worker Charged in 136-Count Indictment for Opioid Prescription Scheme

Noviembre 18, 2022
MINEOLA, N.Y. – Nassau County District Attorney Anne T. Donnelly and Drug Enforcement Administration Special Agent in Charge Frank A. Tarentino III and announced that a Nassau County dentist and a Town of Oyster Bay worker have been indicted for their roles in a scheme to sell opioid prescriptions during...
Noviembre 18, 2022
PRESS RELEASE

Pharmacist Admits Filling Counterfeit Prescriptions Selling Oxycodone and Codeine in Exchange for Cash

Junio 28, 2022
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a pharmacist and pharmacy owner pleaded guilty today to violating the Controlled Substances Act by filling fraudulent and counterfeit...
Junio 28, 2022
PRESS RELEASE

Jury Convicts State Lawmaker of COVID-19 Fraud Scheme at Springfield Health Care Charity

Junio 28, 2022
SPRINGFIELD, Mo. – A Missouri state representative was convicted by a federal trial jury today for a nearly $900,000 COVID-19 fraud scheme, as well as a separate $200,000 fraud scheme in which she made false claims about a fake stem cell treatment marketed through her clinics in southern Missouri, and...
Junio 28, 2022
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Pleads Guilty to Conspiracy to Distribute and Dispense Oxycodone

Junio 16, 2022
Baltimore, Maryland – Norman Rosen, age 84, of Towson, Maryland, pleaded guilty today to conspiracy to distribute and dispense oxycodone in connection with his operation of Rosen-Hoffberg Rehabilitation and Pain Management Associates, P.A., where he was Medical Director and part-owner. The guilty plea was announced by Jarod Forget, Special Agent...
Junio 16, 2022
PRESS RELEASE

North Carolina Pharmacy Agrees to Pay $100,000 Fine

Febrero 03, 2022
DURHAM, N.C. – Aspirar Pharmacy, LLC and Aspirar Pharmacy of Durham, LLC (collectively Aspirar Pharmacy), located in Cary and Durham, North Carolina, respectively, have agreed to pay the United States $100,000 to resolve allegations that they violated the Controlled Substances Act from 2017-2018 by filling prescriptions for a physician who...
Febrero 03, 2022
PRESS RELEASE

Distributor Convicted of Conspiring to Distribute Controlled Substances and Defrauding the DEA

Febrero 02, 2022
NEW YORK – Damian Williams, the United States Attorney for the Southern District of New York announced that Laurence F. Doud III, the former Chief Executive Officer of Rochester Drug Co-Operative, Inc. (RDC), was convicted today in Manhattan federal court of conspiring to distribute unlawfully, oxycodone and fentanyl, and conspiring...
Febrero 02, 2022
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

Enero 27, 2022
Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
Enero 27, 2022
PRESS RELEASE

Suburban Chicago Woman Sentenced to 1 Year for Writing Fraudulent Opioid Prescriptions

Enero 18, 2022
CHICAGO - Robert Bell, Special Agent in Charge for the Drug Enforcement Administration Chicago Division, and U.S. Attorney John R. Lausch, Jr., of the Northern District of Illinois today announced that an administrative assistant at a suburban Chicago medical practice has been sentenced to a year in federal prison for...
Enero 18, 2022
PRESS RELEASE

Bowie Maryland Nurse Practitioner Pleads Guilty to Conspiracy to Distribute and Dispense Oxycodone

Enero 11, 2022
Greenbelt, Md., – Justina Aburime, age 53, of Bowie, Maryland, pleaded guilty today to one count of conspiracy to distribute and dispense oxycodone and one count of distribution and dispensing of oxycodone. The guilty plea was announced by Jarod Forget, Special Agent in Charge of the DEA Washington Division; United...
Enero 11, 2022
Showing 1 - 10 of 12 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster